NEOG - NEOGEN CORP
vs
Region: US
Website: neogen.com
Employees: 2,110
IPO year: 1994
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing
Neogen Corporation develops, manufactures, and markets various products for food and animal safety worldwide. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides.
Neogen® Announces Refinancing of Term Loan and Revolving Credit Facility
LANSING, Mich., April 07, 2025--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today the successful refinancing of the remaining $550 million principal of its original $650 million term loan, as well as its revolving credit facility, due in August 2027.
Read moreSeeking Clues to Neogen (NEOG) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Evaluate the expected performance of Neogen (NEOG) for the quarter ended February 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Read moreNeogen Announces Third-Quarter Earnings Release Date
Neogen® Corporation (NASDAQ: NEOG) will issue its third-quarter earnings release before the opening of the market on Wednesday, April 9, 2025. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results.
Read more